Observational studyCirculation2015

Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.

Géric Maura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.